Chimerix Inc (NASDAQ:CMRX)
| 1.93 Delayed Data As of Sep 28 |  +0.04 / +2.12%Today’s Change | 1.27 Today|||52-Week Range 7.42 | -69.98% Year-to-Date |
Latest CMRX News | Press Releases
| Emergent (EBS) Acquires Worldwide Rights to Smallpox Antiviral Sep 27 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 1.89 |
| Today’s open | 1.95 |
| Day’s range | 1.91 - 1.97 |
| Volume | 47,330 |
| Average volume (3 months) | 4,749,033 |
| Market cap | $159.9M |
Data as of 4:00pm ET, 09/28/2022
Growth & Valuation
| Earnings growth (last year) | -191.43% |
| Earnings growth (this year) | +189.95% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -63.16% |
| P/E ratio | NM |
| Price/Sales | 275.95 |
| Price/Book | 2.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SVRASavara Inc | +0.11 | +7.64% |
| --Ecogreen Internation... | 0.00 | 0.00% |
| GSGTFGensight Biologics S... | 0.00 | 0.00% |
| IPHAInnate Pharma SA | +0.08 | +3.94% |
Data as of 3:55pm ET, 09/28/2022
Financials
| Next reporting date | November 10, 2022 |
| EPS forecast (this quarter) | $2.11 |
| Annual revenue (last year) | $2.0M |
| Annual profit (last year) | -$173.2M |
| Net profit margin | -8,753.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Durham, North Carolina |
Forecasts
